BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Deupsilocin readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Deupsilocin\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06793397-824@assetmemo.bio
DTSTAMP:20261121T004044Z
DTSTART;VALUE=DATE:20270607
DTEND;VALUE=DATE:20270608
SUMMARY:Deupsilocin: Phase 3 readout est. (NCT06793397)
DESCRIPTION:Deupsilocin\, phase 3\, Major Depressive Disorder.\nStudy: A St
 udy of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressi
 ve Disorder\nEstimated primary completion: 7 June 2027. This is a Clinical
 Trials.gov estimate\, not a confirmed readout date\, and it can move.\nDru
 g page: https://assetmemo.bio/drug/deupsilocin#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT06793397
URL:https://assetmemo.bio/drug/deupsilocin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06605105-824@assetmemo.bio
DTSTAMP:20261121T004044Z
DTSTART;VALUE=DATE:20280606
DTEND;VALUE=DATE:20280607
SUMMARY:Deupsilocin: Phase 3 readout est. (NCT06605105)
DESCRIPTION:Deupsilocin\, phase 3\, Major Depressive Disorder.\nStudy: Phas
 e III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in
  MDD (EXTEND)\nEstimated primary completion: 6 June 2028. This is a Clinic
 alTrials.gov estimate\, not a confirmed readout date\, and it can move.\nD
 rug page: https://assetmemo.bio/drug/deupsilocin#upcoming-events\nRegistry
  record: https://clinicaltrials.gov/study/NCT06605105
URL:https://assetmemo.bio/drug/deupsilocin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06820723-824@assetmemo.bio
DTSTAMP:20261121T004044Z
DTSTART;VALUE=DATE:20281130
DTEND;VALUE=DATE:20281201
SUMMARY:Deupsilocin: Phase 2 readout est. (NCT06820723)
DESCRIPTION:Deupsilocin\, phase 2\, Major Depressive Disorder.\nStudy: A Me
 chanistic Study to Assess a Single Dose of CYB003 in Participants With Dep
 ression and Anxiety\nEstimated primary completion: November 2028. This is 
 a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can 
 move.\nDrug page: https://assetmemo.bio/drug/deupsilocin#upcoming-events\n
 Registry record: https://clinicaltrials.gov/study/NCT06820723
URL:https://assetmemo.bio/drug/deupsilocin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
